APOA1 and urinary bladder carcinoma: In a study evaluating the potential of Apo-A1 as a biomarker of bladder cancer, two-dimensional electrophoresis and subsequent MS were used to demonstrate the increased expression of Apo-A1, which was confirmed by Western blot results.